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Cranioectodermal Dysplasia, Sensenbrenner Syndrome,
Is a Ciliopathy Caused by Mutations in the IFT122 Gene
Joanna Walczak-Sztulpa,1,2,* Jonathan Eggenschwiler,3 Daniel Osborn,4 Desmond A. Brown,3
Francesco Emma,5 Claus Klingenberg,6 Raoul C. Hennekam,7,8 Giuliano Torre,9 Masoud Garshasbi,1
Andreas Tzschach,1 Malgorzata Szczepanska,10 Marian Krawczynski,11 Jacek Zachwieja,12
Danuta Zwolinska,13 Philip L. Beales,4 Hans-Hilger Ropers,1 Anna Latos-Bielenska,2,14
and Andreas W. Kuss1,*
Cranioectodermal dysplasia (CED) is a disorder characterized by craniofacial, skeletal, and ectodermal abnormalities. Most cases reported
to date are sporadic, but a few familial cases support an autosomal-recessive inheritance pattern. Aiming at the elucidation of the genetic
basis of CED, we collected 13 patients with CED symptoms from 12 independent families. In one family with consanguineous parents
two siblings were affected, permitting linkage analysis and homozygosity mapping. This revealed a single region of homozygosity with
a signiﬁcant LOD score (3.57) on chromosome 3q21-3q24. By sequencing candidate genes from this interval we found a homozygous
missense mutation in the IFT122 (WDR10) gene that cosegregated with the disease. Examination of IFT122 in our patient cohort
revealed one additional homozygous missense change in the patient from a second consanguineous family. In addition, we found
compound heterozygosity for a donor splice-site change and a missense change in one sporadic patient. All mutations were absent
in 340 control chromosomes. Because IFT122 plays an important role in the assembly and maintenance of eukaryotic cilia, we investi-
gated patient ﬁbroblasts and found signiﬁcantly reduced frequency and length of primary cilia as compared to controls. Furthermore,
we transiently knocked down ift122 in zebraﬁsh embryos and observed the typical phenotype found in other models of ciliopathies.
Because not all of our patients harbored mutations in IFT122, CED seems to be genetically heterogeneous. Still, by identifying
CED as a ciliary disorder, our study suggests that the causative mutations in the unresolved cases most likely affect primary cilia func-
tion too.The etiology of several developmental genetic human
disorders such as Bardet-Biedl (MIM 209900), Senior-
Loken (MIM 266900), Meckel (MIM 249000), Joubert
(MIM 213300), Ellis van Creveld (MIM 225500), and Jeune
syndrome (MIM 208500) has been shown to involve ciliary
dysfunction.1,2 The clinical picture of these ciliopathies is
very variable with a broad range of phenotypes com-
prising, among others, cystic kidney and/or liver, laterality
defects, skeletal changes, and retinal degeneration.1,2
Patients with cranioectodermal dysplasia, also known as
Sensenbrenner syndrome (CED [MIM 218330]), present
with craniofacial, skeletal, and ectodermal abnormalities,
which suggests that this disorder is also a ciliopathic condi-
tion.2,3 In particular, CED patients show similarity to Jeune
syndrome patients, with whom they share short stature,
limb shortening, short ribs, narrow chest, brachydactyly,
renal failure, and hepatic ﬁbrosis.4 Jeune syndrome is
caused by mutations in the ciliogenesis genes IFT80
(MIM 611177) orDYNC2H1 (MIM 603297), but the under-
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The AmeMost of the 20 CED cases reported to date are sporadic,
but a few familial cases support an autosomal-recessive
inheritance pattern. For this study (which was performed
in accordance with the ethical standards of the responsible
committees on human experimentation) we recruited
CED patients from 12 independent families (informed
consent was obtained), including two consanguineous
siblings with typical CED symptoms from a Polish family
(CED-01).
Patient 1, an 8-year-old girl, was the ﬁrst child of healthy
parents who were distantly related. She was born at term
after an uncomplicated pregnancy with a birth weight of
3.6 kg (50th centile), body length of 57 cm (97th centile),
head circumference (OFC) of 35 cm (50th centile), and
chest circumference of 34 cm (50th centile). Dysmorphic
signs noticed at birth comprised short limbs, protuberant
abdomen, brachydactyly, dolichcephaly, high forehead,
prominent auricles, full cheeks, telecanthus, broad nasal
bridge, and low-set prominent ears. Clinical examinations
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Figure 1. Consanguineous CED Patients
(A) CED-01, female patient 1 at the age of
4 years: note limb shortening, brachydac-
tyly, short narrow thorax, protuberant
abdomen, thin sparse hair, dolicho-
cephaly, high prominent forehead, full
cheeks, hypertelorism, small ﬂat nose,
full lower lip, prominent auricles, and
small abnormally shaped teeth.
(B) CED-01, male patient 2 at the age of
4 months (left pane) and 1 year (right
panes): note limb shortening, pectus exca-
vatum, bilateral large inguinal hernias,
characteristic face (similar to female), and
skin laxity.and abnormally shaped teeth, sparse hair, skin laxity, and
abnormal nails, and she had bilateral inguinal hernias
(Figure 1A and Table 1). In the ﬁrst year of life she had
frequent respiratory infections. Signs of renal insufﬁciency
(diminished glomerular ﬁltration rate) were detected for
the ﬁrst time at the age of 4 years. A renal ultrasound
scan showed normal size of both kidneys with decreased
corticomedullary differentiation. Stage 1 chronic kidney
disease due to tubulo-interstitial nephropathy without
liver abnormalities was diagnosed. At the age of 5 years,Table 1. Clinical Features of CED Patients with and without IFT122 M
Family CED-01 CED-01 CED-02 CED-03
Patient 1 2 3 4
Age at examination 4–8 years 0 months–4
years
12 months 4.5 years
IFT122 mutation V553G V553G S373F W7C;
c.502þ5G>A
Sex female male male male
Psychomotor
development
normal normal normal normal
Dolichocephaly þ þ þ þ
Characteristic face þ þ þ þ
Dental anomalies þ þ þ þ
Sparse hair þ þ þ 
Short/narrow
thorax
þ þ þ þ
Limb shortening þ þ þ þ
Short ﬁngers þ þ þ þ
Bilateral inguinal
hernias
þ þ þ þ
Skin laxity þ þ þ þ
Renal failure þ þ þ þ
Liver disease  hepatomegaly NA hepatic
ﬁbrosis
Retinal dystrophy    
‘‘þ’’ indicates feature present; ‘‘’’ indicates feature not reported; NA indicates d
950 The American Journal of Human Genetics 86, 949–956, June 11,she had a weight of 14.5 kg (5th centile), a height of
104 cm (25th centile), and a head circumference of 49.5 cm
(50th centile). Psychomotor development was normal and
ophthalmological analysis revealed no evidence of retinal
dystrophy. Chromosome analysis showed a normal female
karyotype (46, XX).
Her brother (patient 2) was born after an uncomplicated
pregnancy with a birth weight of 3.5 kg (50th centile) and
body length of 54 cm (90th centile). Dysmorphic features
were nearly identical to those of his sister (Figure 1B andutations
CED-04 CED-05 CED-06 CED-07 CED-08 CED-09 CED-10
5 6 7 8 9 10 11
3 years 15 months 7 years 5 years 2 years 4 years 6 years
none none none none none none none
male female female male male female male
normal normal delayed normal normal normal normal
þ þ  þ þ þ þ
þ þ þ þ þ þ þ
þ þ þ þ þ þ þ
þ þ þ þ þ þ þ
þ þ þ þ þ þ þ
þ þ þ þ þ þ þ
þ þ þ þ þ þ þ
      
   NA NA þ þ
þ þ þ þ þ þ þ
      
þ   NA   
ata not available.
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Figure 2. Linkage Interval, Pedigrees, and IFT122 Mutations
(A) Linkage interval on chromosome 3q21-3q24 (arrow) with a signiﬁcant LOD score (3.57).
(B) Simpliﬁed pedigrees and IFT122 mutations. CED-01: Consanguineous Polish family with two affected siblings (patients 1 and 2)
homozygous for p.V553G. CED-02: Consanguineous Norwegian family (patient 3 homozygous for p.S373F). CED-03: Sporadic patient
4, who is a compound heterozygote for a splice-site mutation (c.502þ5G>A) and p.W7C. Filled symbols indicate CED patient status.Table 1). Blood tests at the age of 29 days revealed elevated
creatinine values. Renal function deteriorated rapidly over
the following months, and by the age of 3.5 years he had
developed end-stage renal failure, and peritoneal dialysis
was started. Ultrasound scans showed decreased size of
both kidneys with increased echogenicity. The liver was
enlarged and showed structural heterogeneity with hypoe-
chogenic streaked foci along the strongly hyperechogenic
portal vessels. Mental and motor development were nor-
mal. Ophthalmological examination showed no evidence
of retinal dystrophy. Chromosome analysis revealed a
normal male karyotype (46, XY).
In order to localize the disease-causing genetic defect in
this family, we ﬁrst performed linkage analysis and homo-
zygosity mapping by using the Affymetrix GeneChip
human Mapping 10K Array8 for genotyping both affected
children and their parents. Genome-wide multipointThe Amelinkage analysis was performed with the Merlin9 software
under the assumption of a fourth-cousin marriage, a fully
penetrant autosomal-recessive trait with a disease fre-
quency of 0.001, and no phenocopies as described previ-
ously.10 This revealed a single region of homozygosity with
a signiﬁcant LOD score (3.57) on chromosome 3q21-3q24
(Figure 2A; see Figure S1 available online for haplotype
information), spanning 16.7 Mbp (between rs977683 and
rs1992093) and containing 124 RefSeq protein-coding
genes.
Sequencing of the coding regions and exon-intron
boundaries of 79 candidate genes from this interval
(Table S1) revealed a homozygous missense mutation
(p.V553G) in the IFT122 (WDR10 [MIM 606045]) gene
that cosegregated with the disease (Figure 2B, CED-01).
The main transcript of IFT122 encodes a 1292 amino
acid cytoplasmic protein that has a molecular weight ofrican Journal of Human Genetics 86, 949–956, June 11, 2010 951
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Figure 3. Compound Heterozygosity for c.502þ5G>A and p.W7C in Patient 4, CED-03
Chromatograms show sequencing results corresponding to the affected codon of p.W7C obtained with exon 6 speciﬁc primers (A) as
well as primers speciﬁc for the new transcript with exon 6 skipping (B) and for isoform 4, which lacks exon 6 by default (C). Results
of qPCR experiments for the corresponding amplicons show a signiﬁcant (Student’s t test, p < 0.01) loss of (exon 6-containing) isoform
3 (D) and a highly signiﬁcant (p< 0.001) increase in expression of the transcript with exon 6 skipping (E) in RNA extracted from patient
blood. Expression of isoform 4 was unaltered (F). Error bars represent the standard deviation (n ¼ 3). Expression of the GAPDH gene was
used for normalization.approximately 140 kDa and contains seven WD40
domains, which are involved in the formation of
b-propeller structures acting as platform for the association
of binding partners.11 As a component of the intraﬂagellar
transport complex A, the IFT122 protein is involved in
retrograde ciliary transport, which returns proteins from
the tip of the cilia to the cell body and plays an important
role in the assembly and maintenance of eukaryotic cilia
and ﬂagella.12,13
We next examined IFT122 in the patients from the re-
maining 11 families of our cohort and identiﬁed one addi-
tional homozygous missense change (p.S373F) in a patient
from a second consanguineous family14 (Figure 2B, CED-
02, patient 3). In addition, we found putative compound
heterozygosity for two different IFT122 mutations in
patient 4, a previously described sporadic case15 (Figure 2B,
CED-03, patient 4). This patient carried a donor splice-site
change in intron 6 (c.502þ5G>A) that was inherited from
the mother in combination with a missense change in
exon 1 (p.W7C) that was not found in either parent.952 The American Journal of Human Genetics 86, 949–956, June 11,Because paternity could be conﬁrmed by an independent
genotyping experiment with DNA from the father, this
mutation can be considered to have arisen de novo. To
test our hypothesis that this change affects the paternal
IFT122 allele, leading to compound heterozygosity with
the maternally inherited splice-donor change (c.502þ
5G>A), we performed RT-PCR with a series of primer com-
binations on RNA extracted from patient blood (Table S3).
Human IFT122 is composed of 31 exons with at least
four alternatively spliced variants that are expressed in
multiple tissues (Genome Browser, Human Protein Refer-
ence Database). Our experiment showed that in blood at
least three transcripts are expressed, including the known
isoforms 3 (comprising exons 1, 2, 3, 4, 6, 7, 8, 10, and
11) and 4 (comprising exons 1, 2, 3, 7, 8, 10, and 11) as
well as a new transcript also without exon 6 (comprising
exons 1, 2, 3, 4, 7, 8, 10, and 11) (Figures S2 and S3).
Subsequent sequencing revealed that in patient 4 the
amplicon speciﬁc for isoform 3 was homozygous for
p.W7C (Figure 3A), suggesting that this isoform is2010
expressed from only one (paternal) allele. Amplicons corre-
sponding to the new transcript without exon 6 or to iso-
form 4 were both heterozygous for the corresponding mis-
sense change, showing that these variants are expressed
from both alleles (Figures 3B and 3C).
To quantify the RT-PCR results we performed real-time
PCR (see Supplemental Data, available online, for details)
with primer combinations that were speciﬁc for isoform
3, isoform 4, and the new transcript of IFT122 (Table S4).
The experiments were carried out on an Applied Biosys-
tems 7900 instrument, in 96-well optical reaction plates
(Applied Biosystems, Foster City, CA). Additional dissocia-
tion curves of the products were created. Each amplicon
was analyzed in triplicate. Expression of the GAPDH gene
was used for normalization.
This analysis showed that in patient cells IFT122 isoform
3 expression was signiﬁcantly reduced whereas the tran-
script resulting from the skipping of exon 6 showed highly
signiﬁcant (p< 0.001) enrichment as compared to controls
(Figures 3D and 3E). Expression of isoform 4 that does not
contain exon 6 by default and is not affected by the splice-
site mutation was unaltered (Figure 3F).
These observations are in line with the assumption that
c.502þ5G>A leads to skipping of exon 6 and thus to an
out-of-frame transcript with premature termination of
translation of the affected allele. Because all sequences
that could be obtained from exon 6-containing transcripts
exclusively contained p.W7C, they must be derived from
the other allele, thus proving the assumed compound
heterozygosity in patient 4. The p.W7C change, however,
like the two homozygous mutations p.V553G and p.S373F,
affects a highly conserved amino acid in all four alterna-
tively spliced variants. All three missense mutations are
located within or close to a WD40 domain (Figure S2)
and were predicted to have a deleterious effect on IFT122
function by the PolyPhen software. None of the changes
were found in 340 chromosomes from ethnically matched
controls. Clinical features reported for patients with and
without mutations in IFT122 are summarized in Table 1.
The four patients with IFT122 mutations did not show
grave phenotypic differences from the nine patients
without mutations, and the preponderant overlap of clin-
ical features between all patients suggests that CED, like
other ciliary syndromes, is genetically heterogeneous.
To understand the impact of the mutant IFT122 tran-
scripts and corresponding protein, we investigated the
abundance and morphology of primary cilia in ﬁbroblasts
from patient 2 (the male patient from family CED-01)
under different culture conditions.
Control ﬁbroblasts from three independent, healthy
German individuals were provided by the Department of
Human Molecular Genetics of the Max Planck Institute
for Molecular Genetics. Control and patient ﬁbroblasts
(patient 2) were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum, glutamine, and penicillin and streptomycin. Cells
were plated onto coverslips coated with gelatin (Chemi-The Amecon) or ﬁbronectin (R&D Systems) at 105/cm2. Medium
was replaced with OptiMem (GIBCO) and cultured for
72 hr. Cells were then ﬁxed, blocked in 10% serum, and
stained with mouse anti-acetylated a-tubulin (Sigma,
1:2500) at 4C overnight. Cells were then washed and
incubated overnight with Cy2-labeled secondary anti-
bodies (Jackson ImmunoResearch) and TO-PRO-3 (Invitro-
gen) at 4C, washed again, and mounted. Three coverslips
for each of six cell lines (three control and three CED lines)
were imaged with a PerkinElmer RS3 Spinning Disk Con-
focal Microscope with a Hamamatsu C9100-13 EMCCD
camera. For frequency analysis, a-tubulin-stained cilia
and TO-PRO-3-labeled nuclei were counted from 15 pro-
jected Z-stack images (ﬁve per coverslip) for each cell
line. The average frequency across the three cell lines per
genotype was determined and statistical signiﬁcance was
assessed by z-score analysis. Cilia lengths were measured
with the National Institutes of Health (NIH) ImageJ soft-
ware, and values were subjected to t tests.
These experiments showed signiﬁcantly reduced cilia
frequency and length in patient ﬁbroblasts as compared
to three independent controls (Figures 4A–4D).
To corroborate our hypothesis that the IFT122 muta-
tions we identiﬁed are functionally relevant and therefore
responsible for the patient phenotype, we next transiently
knocked down ift122 in zebraﬁsh embryos, by using an
antisense morpholino against the 50UTR (50-AAATCACGG
CGTTTCCGAAAGCCGC-30) immediately upstream of the
start ATG as well as a second one targeting the exon
1-intron 1 splice boundary (50-TATTGGTCTCTTTACCAG
AACTCTG-30) of Danio rerio ift122 (Figure S4).
Wild-type ﬁsh (AB 3 Tup Longﬁn) were staged and
maintained according to standard protocols.16 Embryos
were injected with 4–8 ng of morpholino at the 1–2 cell
stage and incubated at 28.5C until the desired age. Fluo-
rescent antibody staining for a- and g-Tubulin (Sigma,
T6793 and T6667, 1:500) was used to mark the cilia and
centrosomes, respectively, and was performed on 4% PFA
ﬁxed embryos with the appropriate Alexa secondary anti-
bodies (1:1000). In situ hybridization for shha7 and
ptc18 was performed via standard protocols.17 Fluorescent
images were captured on a Zeiss LSM710 confocal
microscope.
In 80 hr postfertilization (hpf) embryos injected with
either morpholino, we observed several defects including
shortened body axis and curvature (consistent with a
convergent extension defect), cardiac edema, and small
eyes (Figure 5A). In addition, at 5 dpf, morphants displayed
pronephric cysts and a distended cranium consistent with
hydrocephalus and otolith defects (Figure 5A). Thus, ift122
morphant zebraﬁsh embryos display the typical pheno-
type observed in many other ciliopathies models (e.g.,
Bardet-Biedl syndrome, Jeune syndrome, and nephro-
nophthisis [MIM 256100]).18–20
Because CED patients suffer from renal failure and cilia
dysfunction and/or immotility is thought to underlie
the pronephric duct dilation and cyst formation, we nextrican Journal of Human Genetics 86, 949–956, June 11, 2010 953
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Figure 4. Primary Cilia in Control and CED Patient Fibroblasts
(A) Primary cilia from serum-starved primary ﬁbroblasts stained with anti-acetylated-tubulin (green). Nuclei are counterstained with
TO-PRO-3 (red). The scale bar represents 10 mm.
(B) High magniﬁcation of cilia showing difference in axonemal lengths. The scale bar represents 1 mm.
(C) Signiﬁcant diffrences (p < 0.001) in average cilia frequency between control and CED patient ﬁbroblast lines plated on gelatin and
ﬁbronectin (FN). Error bars represent the standard error of the mean (SEM).
(D) Signiﬁcant diffrences (p < 0.05) in average axomenal lengths between patient and control. Error bars represent the SEM.examined the cilia in the pronephric duct (PND) of mor-
phant embryos. Whereas cilia and their basal bodies were
abundant in control embryos (24 hpf), their numbers in
morphants were dramatically reduced (Figure 5B). Con-
sistent with the patient ﬁbroblast analysis, primary cilia
shortening was observed in the zebraﬁsh Kupffer’s vesicle
(Figure 5C).
Another consistent feature in CED is brachydactyly,
which can be caused by impairment of the sonic hedgehog
(shh) signaling pathway.21 Because shh signal transduc-
tion involves intraﬂagellar transport,13,22 we investigated
shh signaling in our zebraﬁsh morphants and found the
expression of the directly regulated target gene ptc1 dimin-
ished and expanded (Figure 5D). This conﬁrms the require-
ment of Ift122 for shh signal transduction and provides an
explanation for the skeletal features observed in CED
patients. We recognize that the use of antisense morpholi-
nos is not without limitations and ideally a zebraﬁsh
mutant would be preferable; however, such a line is not
yet available. One concern of morpholinos is the potential
for off-target effects, especially upregulation of p53. We954 The American Journal of Human Genetics 86, 949–956, June 11,have excluded this possibility by using p53 morpholinos,
in whose morphants we do not see any difference from
ﬁsh injected with target morpholino alone (data not
shown). As for determining the speciﬁcity of our ift122
ATG-morpholino, in the absence of a suitable zebraﬁsh
antibody we designed two additional splice-site morpholi-
nos. Both of these gave rise to a phenotype identical to the
ATG-morpholino, suggesting that we are successfully tar-
geting ift122 and that the remaining possibility for some
aspects of the morphant phenotypes to be nonspeciﬁc in
origin is rather small.
Defects in cilia formation and function lead to broad
pleiotropic phenotypes, which is probably due to their
ubiquitous presence inmany different cell types. In a previ-
ously described mouse model, Ift122 null mutant embryos
showmultiple developmental defects that result in a lethal
phenotype.23 In embryonic ﬁbroblasts from these mice,
cilia are completely absent. However, a second mouse
Ift122 null allele on a different strain background causes
a ciliary phenotype more similar to the one we describe
in patient ﬁbroblasts: murine embryonic ﬁbroblasts from2010
Figure 5. Loss of ift122 in Zebrafish Results in a Ciliopathy-
Related Phenotype
(A) Gene-speciﬁc knockdown by morpholino modiﬁed antisense
oligonucleotides to either the 50UTR or to the exon 1-intron 1
splice boundary of ift122 caused reduced ocular development,
melanocyte mislocalization, curly tails, renal cysts, and heart
edemas by 5 dpf. All common features related to loss of ciliary
genes in zebraﬁsh. The scale bar represents 400 mm.
(B) Ift122 morphants display reduced and shortened motile cilia.
Immunoﬂuorescence staining for cilia (acetylated a-tubulin, red),
centrosomes (g-tubulin, green), and nuclei (DAPI, blue) in the
pronephric duct (PND) shows reduced centrosome numbers and
interrupted and/or shortened cilia in morphant compared to
control embryos. The scale bar represents 10 mm.
(C) Cilia in the KVof ift122 Spl. Morphants are visibly shorter than
uninjected controls. The scale bar represents 5 mm.
(D) A mild reduction in Hh signaling was observed in morphant
embryos. Embryos were analyzed for either shha or ptc1 by
in situ hybridization at 24 hpf; images of the head and somites
(at approximately the somite 15 position) are displayed for
comparison. Shha accumulates in the ﬂoor plate of the neural
tube and in the notochord (at low levels) at the 24 hpf stage;
this expression remains unperturbed in morphant embryos. Ptc1
appears to be globally reduced in ift122morphants, most notably
in the somites (see asterisk) where ptc1 is normally abundant in
The Amethese animals generate cilia, although at a reduced fre-
quency. Such cilia are somewhat shortened and exhibit
dramatic swelling at their tips with an accumulation of
anterograde intraﬂagellar-transport proteins (e.g., Ift88),
which is consistent with disturbed retrograde intraﬂagellar
transport (J. Qin and J.E., unpublished data).
That the IFT122mutations found in our patients are still
compatible with life is probably due to the fact that they do
not completely abolish the IFT122 gene product but rather
lead to hypomorphic forms of the protein, which impair
cilia formation and function.
Taken together, our results show that hypomorphic
mutations in IFT122 cause a ciliary phenotype in homozy-
gous carriers, which is reﬂected in zebraﬁsh morphants.
As in other ciliary disorders, the CED clinical phenotype
is pleiotropic because of the involvement of cilia in amulti-
tude of tissues and during many developmental stages, as
well as because of the role of cilia in morphogenetic signal
transduction.13,22,24
Because only 4 out of the 13 CED patients in our cohort
harbored mutations in IFT122, it must be assumed that
this disorder is genetically heterogeneous. This is only
the second IFT gene in which human mutations have
been discovered, and it highlights the diverse nature of
the resulting phenotype compared with IFT80. One of
the key differences distinguishing CED from Jeune
syndrome is the presence of skin and dental dysplasia,
and so it remains to be determined whether primary cilia
and IFT in particular are required for ectoderm develop-
ment.Supplemental Data
Supplemental Data include four ﬁgures and four tables can be
found with this article online at http://www.ajhg.org.Acknowledgments
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